AIM ImmunoTech (AIM) announced its initiation of a plan to advance Ampligen as a vaccine adjuvant for avian influenza as part of the Company’s ...

Klaus joins Epitopea after serving as Chief Development Officer (CDO) at Nykode Therapeutics, where he oversaw clinical development, regulatory affairs, and project management across oncology, ...

AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Karl Matchett and Whitehall editor Kate ...

Pharma giant AstraZeneca urged Britain to improve the environment for businesses in order to drive investment, days after it ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...

AstraZeneca PLC (NASDAQ:AZN – Free Report) – Research analysts at Zacks Research ... focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

AstraZeneca research and development oncology haematology executive vice-president Susan Galbraith stated: “With 57% of patients still alive at three years in the ADRIATIC trial, Imfinzi has the ...

The situation escalated with the arrest of Leon Wang, AstraZeneca’s Executive Vice President International and China President. This development ... analysis of our research processes.

A Liberal Democrat peer has accused the government of favouring the south-east of England over Merseyside after AstraZeneca ... we can make sure that [research and development] funding is ...

"AstraZeneca will have a strong base for considerable expansion, especially in research and development and geographical presence. I am convinced that we will see considerable growth in the years ...

AstraZeneca has teamed up with DNA sequencing ... and protein expression. The research collaboration will explore the use of the two companies' technologies side by side to find targets across ...